Avita Drugs Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Avita Drugs

Access the complete profile.

Avita Drugs Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	44611 Pharmacies & Drug Stores
Address	5700 Granite Parkway, Suite 425 Plano, TX 75024

Note: Revenues for privately held companies are statistical evaluations.


Avita Drugs's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Avita Drugs's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Avita Drugs is classified as operating in the Pharmacies & Drug Stores industry, NAICS Code 44611.

Avita Drugs Annual Revenue and Growth Rate

Avita Drugs	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Avita Drugs's revenues are gauged from an analysis of company filings.

Avita Drugs's Income Statement (based on Industry Averages)

Avita Drugs P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Avita Drugs is developing and marketing. Avita Drugs doesn't have any recent trademark applications, indicating Avita Drugs is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
BE FEARLESS GET TESTED Promoting public awareness of testing, diagnosis, prevention, and treatment of hiv/aids	12/21/2023
AVITA CARE SOLUTIONS Computer software platforms, downloadable, for providing telehealth services focused on primary care medical services for people with HIV and the LGBTQ+ community and to promote sexual health; downloadable software application for providing telehealth services focused on primary care medical services for people with HIV and the LGBTQ+ community and to promote sexual health	02/02/2023
AVITA CARE Primary care medical services for people with HIV and the LGBTQ+ community	02/02/2023

See all trademarks and details in the Full Report.

Market Share of Avita Drugs's Largest Competitors

A competitive analysis shows these companies are in the same general field as Avita Drugs, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CVS HEALTH	Woonsocket, RI	100
CVS PHARMACY	Woonsocket, RI	39
WALGREEN	Deerfield, IL	35
RITE AID	Harrisburg, PA	4
TRULIEVE	Tallahassee, FL	1
TRULIEVE	Clearwater, FL	1
KPH HEALTHCARE SERVICES	Gouverneur, NY	1
PHARMERICA	Louisville, KY	1

Nearby Competitors

These companies are similar in business line and location to Avita Drugs. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SOLEO HEALTH HOLDINGS	Frisco, TX	100
AVITA DRUGS	Plano, TX	52
ALIXA RX	Plano, TX	45
EWC CORPORATE	Plano, TX	25
BEAUTY MANUFACTURING SOLUTIONS	Coppell, TX	23
FRUIT OF EARTH	Grand Prairie, TX	17

Future Competition: Avita Drugs's Fastest Growing Competitors

These companies are in the same general field as Avita Drugs and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)